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CNPA, also called semi-invasive or subacute invasive aspergillosis, usually affects middle-aged and elderly patients with mildly immunocompromised status, such as diabetes mellitus and alcoholism. 1 This entity is rare and usually associated with preexisting structural lung disease such as COPD, previous pulmonary tuberculosis and thoracic surgery. 1 Particular risk factors in our case were old cavitary tuberculosis and diabetes mellitus. Antifungal therapy with voriconazole is the primary drug of choice for CNPA. 2 In this patient, voriconazole 200 mg was given intravenously twice daily for a period of 4 weeks. Clinical improvement was evident despite no interval change of radiological figure.
